RecruitingNCT03409159
Austrian Left Atrial Appendage Closure Registry
Sponsor
Medical University of Graz
Enrollment
200 participants
Start Date
May 16, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients who received LAAC in Austria
Exclusion Criteria1
- Absence of informed consent
Interventions
DEVICELAAC
Left atrial appendage closure
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03409159
Related Trials
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
The CONFORM Pivotal Trial
NCT0514779283 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT0645509846 locations
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698127 locations